Development of microfusion techniques to generate human hybridomas

scientific article published on November 1990

Development of microfusion techniques to generate human hybridomas is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0022-1759(90)90109-9
P8608Fatcat IDrelease_dnflufe6xnex7ktxxmylunvofq
P698PubMed publication ID2172386

P2093author name stringZimmermann U
Gessner P
Kafadar K
Perkins S
Foung S
P433issue1
P304page(s)35-42
P577publication date1990-11-01
P1433published inJournal of Immunological MethodsQ15755939
P1476titleDevelopment of microfusion techniques to generate human hybridomas
P478volume134

Reverse relations

cites work (P2860)
Q67814802A simple and improved method to generate human hybridomas
Q36048830B cell responses to HIV and the development of human monoclonal antibodies
Q40790301CD19+ B lymphocytes are the major source of human antibody-secreting hybridomas generated by electrofusion
Q39680503Cell-cell electrofusion: optimization of electric field amplitude and hypotonic treatment for mouse melanoma (B16-F1) and Chinese Hamster ovary (CHO) cells
Q42285511Comparison of alkaline lysis with electroextraction and optimization of electric pulses to extract plasmid DNA from Escherichia coli
Q72374665Effect of electric field pulses on the viability and on the membrane-bound immunoglobulins of LPS-activated murine B-lymphocytes: correlation with the cell cycle
Q71617657Efficient production of IgG human monoclonal antibodies by lymphocytes stimulated by lipopolysaccharide, pokeweed mitogen, and interleukin 4
Q30835752Exploring the native human antibody repertoire to create antiviral therapeutics
Q39997497Generation of human monoclonal antibodies recognising membranous antigens of the lung adenocarcinoma cell line A549 using an AMeX immunohistostaining method
Q41574609Hypotonically induced changes in the plasma membrane of cultured mammalian cells
Q73308403Preparation of human-mouse heterohybridomas against an immunising antigen
Q42079118Relationship between antibody productivity by activated human lymph node lymphocytes from lung cancer patients and lymphocyte subsets
Q40876696The new antibody technologies.

Search more.